BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus]. 1978

P Polosa, and L Mughini

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005907 Gliclazide An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Diabrezide,Diaglyk,Diaikron,Diamicron,Gen-Gliclazide,Gliklazid,Glyade,Glyclazide,Novo-Gliclazide,S-1702,S-852,Gen Gliclazide,Novo Gliclazide,S 1702,S 852,S1702,S852
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

P Polosa, and L Mughini
New oral hypoglycemic drug--gliclazide--in the treatment of maturity onset diabetes mellitus.
March 1988, Indian journal of medical sciences,
P Polosa, and L Mughini
[Therapeutic activity, in diabetes mellitus, of a new oral hypoglycemic agent (chlorpropamide)].
August 1959, Minerva medica,
P Polosa, and L Mughini
[Therapeutic value of a new oral antidiabetic agent: gliclazide].
March 1978, La Clinica terapeutica,
P Polosa, and L Mughini
Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent.
January 1973, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
P Polosa, and L Mughini
[Gliclazide, a new molecule in the treatment of non-insulin-dependent diabetes mellitus].
February 1980, La Revue du praticien,
P Polosa, and L Mughini
Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
June 1972, Israel journal of medical sciences,
P Polosa, and L Mughini
MANAGEMENT OF DIABETES MELLITUS WITH A NEW MORE ACTIVE, ORAL, HYPOGLYCEMIC AGENT "ACETOHEXAMIDE".
January 1964, The Journal of the Egyptian Medical Association,
P Polosa, and L Mughini
[The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets].
April 1974, Thrombosis research,
P Polosa, and L Mughini
Oral treatment of diabetes mellitus: the contribution of gliclazide.
June 1991, The American journal of medicine,
P Polosa, and L Mughini
Experiences with an oral hypoglycemic agent in diabetes mellitus.
May 1958, The Illinois medical journal,
Copied contents to your clipboard!